Establishing Traphaco Pharmaceutical One Member Limited Company – A strategic milestone in distribution system restructuring

The Ceremony to Announce the Establishment Resolution and the Appointment of the General Director of Traphaco Pharmaceutical One Member Limited Company

On July 2, 2025, at the headquarters of Traphaco Joint Stock Company, the Ceremony to Announce the Establishment Resolution and the Appointment of the General Director of Traphaco Pharmaceutical One Member Limited Company was formally held. This milestone marks a strategic move in Traphaco’s efforts to restructure its logistics system, aligning with the broader objectives set forth for 2025. Pursuant to the Decision issued by the Board of Directors, Mr. Thái Đức Luận – Licensed Pharmacist and Master of International Business Administration – was officially appointed as the General Director and is concurrently serving as the Acting Chairman of Traphaco Pharmaceutical One Member Limited Company.

In 2025, amidst ongoing economic challenges and emerging opportunities, Traphaco has set ambitious business targets with projected revenue reaching VND 2,559 billion and profit of VND 268 billion, representing an 8% year-on-year growth. From the outset of the year, the company has proactively decomposed its goals, allocated resources, and launched an internal emulation program titled “Creative Innovation – Rising to Thrive”, emphasizing mindset transformation and the adoption of digital technologies and AI as essential drivers of performance improvement. Notably, Traphaco has identified seven strategic priorities, with the restructuring of the distribution and logistics system positioned as the top priority – underscoring the company’s commitment to enhancing operational efficiency and logistics excellence within the pharmaceutical industry. This vision laid the groundwork for the establishment of Traphaco Pharmaceutical One Member Limited Company.

Mr. Thái Đức Luận receives the Decision of Appointment as General Director of Traphaco Pharmaceutical One Member Limited Company and congratulatory flowers from Mr. Nguyễn Phú Khánh – Vice Chairman of the Board of Directors of Traphaco JSC, and Mr. Trần Túc Mã – the CEO of Traphaco JSC

According to the resolution passed on May 23, 2025, Traphaco Pharmaceutical One Member Limited Company was established with a charter capital of VND 40 billion, wholly owned by Traphaco Joint Stock Company. The company’s details are as follows:

Vietnamese Name: CÔNG TY TNHH MỘT THÀNH VIÊN DƯỢC PHẨM TRAPHACO
English Name: TRAPHACO PHARMACEUTICAL ONE MEMBER LIMITED COMPANY
Abbreviated Name: TRAPHACO PHARMA CO., LTD
Enterprise Code: 0111120648
Head Office: Alley 15, Ngoc Hoi Street, Yen So Ward, Ha Noi City, Vietnam
Phone: +84 243 6811855
Email: infolog@traphaco.com.vn

The company’s main business activities encompasses all logistics activities, including warehousing, inventory   management,   delivery,   and   cash   collection. Product portfolio includes: Pharmaceutical products registered under Traphaco’s ownership, imported by Traphaco, or co-developed for the Vietnamese market; and products under distribution agreements signed by the company.

Its organizational structure comprises a Chairman, a General Director, and two functional departments: the Provincial Delivery Management Department and the General Affairs Department. The General Director shall act as the legal representative of the company. The Board of Directors also assigned the CEO of Traphaco JSC and relevant departments to complete all legal procedures, finalize the company’s charter and internal regulations, and ensure the subsidiary operates with greater efficiency than the current standard at the parent company.

Mr. Thái Đức Luận – General Director of Traphaco Pharmaceutical One Member Limited Company delivers his inaugural speech

The formation of Traphaco Pharmaceutical One Member Limited Company is not only an organizational advancement but also a strong affirmation of Traphaco’s new distribution strategy. In the pharmacy channel, the company is streamlining its salesforce, establishing a specialized order management center, tailoring KPIs by region, and deploying QR-based technology to control inventory and pricing transparency. Simultaneously, Traphaco is strengthening B2B partnerships with major pharmacy chains such as Long Châu, Pharmacity, and An Khang, capitalizing on its brand strength and media presence to expand market coverage and drive revenue growth. In the hospital channel, the company is actively recruiting specialized personnel and expanding its product portfolio, aiming to increase the channel’s contribution to overall sales in the near future. With this strategic initiative, Traphaco Pharmaceutical One Member Limited Company is poised to serve as a robust operational foundation, elevating Traphaco’s competitiveness and reinforcing its leadership position in Vietnam’s pharmaceutical market.